Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Safety and efficacy of surovatamig (AZD0486) in adolescent and adult patients with relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL): Updated Results from the Phase 1/2 SYRUS study

Blood (2025) 146 (Supplement 1): 3345.

https://doi.org/10.1182/blood-2025-3345

Published: 2025

Journal Articles

Genetic evolution in CML patients from diagnosis to TKI failure: An analysis of 121 paired diagnosis and treatment failure samples

Ying-Jung Huang, Ming-Chung Kuo, Tung-Liang Lin, Ming-Chun Ma, Chieh-Lin Jerry Teng, Young-Sen Yang, Tsai-Yun Chen, Chiu-Chen Chen, Cheng-Shyong Chang, Hung Chang, Ting-Yu Huang, Tung-Huei Lin, Yen-Min Huang, Su-Peng Yeh, Ming-Chung Wang, Lee-Yung Shih

Blood (2025) 146 (Supplement 1): 5555.

https://doi.org/10.1182/blood-2025-5555

Published: 2025

Journal Articles

Acalabrutinib versus venetoclax plus obinutuzumab in treatment-naive chronic lymphocytic leukemia: A real-world propensity score-matched study

Chieh-Lin Jerry Teng, Yu-Min Liao, Bo-Wei Liao

Blood (2025) 146 (Supplement 1): 5662.

https://doi.org/10.1182/blood-2025-5662

Published: 2025

Journal Articles

Real World Experience with Time Limited Venetoclax and Obinutuzumab (VO) for Frontline Treatment of CLL/SLL with MRD Determination By Clonoseq®

Allison M. Winter, Olivia Landever, Hiruni Mendries, Willem Van Heeckeren, Chieh-Lin Fu, Robert M. Dean, Taylor R. Brooks, Deepa Jagadeesh, Paolo F. Caimi, Brian T. Hill

Blood (2024) 144 (Supplement 1): 3247.

https://doi.org/10.1182/blood-2024-200306

Published: 2024

Journal Articles

Doxorubicin Synergizes Bortezomib-Induced Multiple Myeloma Cell Death By Inhibiting Aggresome Formation Leading to ER Stress and Apoptosis

Yin-Che Wang, Yu-Min Liao, Chieh-Lin Jerry Teng

Blood (2024) 144 (Supplement 1): 6810.

https://doi.org/10.1182/blood-2024-194605

Published: 2024

Journal Articles

Pomalidomide Induces Myeloma Cell Death Via GPX4-Mediated Ferroptosis

Yin-Che Wang, Chieh-Lin Jerry Teng, Yu-Min Liao

Blood (2024) 144 (Supplement 1): 6837.

https://doi.org/10.1182/blood-2024-193750

Published: 2024

Journal Articles

Real-World Treatment Patterns and Outcomes of Solitary Plasmacytoma in the United States: A National Cancer Database (NCDB) Analysis of Years 2004-2020

Ludovic Saba, Chieh-Lin Fu, Kaylee Sarna, Hong Liang, Barbara Geraldine Dominguez, John Greskovich, Jr., Chakra Pani Chaulagain

Blood (2023) 142 (Supplement 1): 2025.

https://doi.org/10.1182/blood-2023-181057

Published: 2023

Journal Articles

Final Results of a Phase I/II Trial of Carfilzomib + R-CHOP for Frontline Treatment of Patients with Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL)

Brian T. Hill, Pallawi Torka, Francisco J. Hernandez-Ilizaliturri, Robert M. Dean, Deepa Jagadeesh, Kasra Karamlou, Chieh-Lin Fu, Allison Winter, Ethan Krauspe, Jonathan Zhou, Taylor R. Brooks, Merve Kacar, Ben K. Tomlinson, Brenda W Cooper, Hong Li, Xuefei Jia, Yanwen Chen, Jenna Thomas, Paolo F. Caimi

Blood (2023) 142 (Supplement 1): 3087.

https://doi.org/10.1182/blood-2023-173943

Published: 2023

Journal Articles

No Survival Disparity between Black and White Patient's with Stage I/II Diffuse Large B-Cell Lymphoma and It's Significance

Sindu Iska, Ludovic Saba, Hong Liang, Barbara Geraldine Dominguez, Chakra Pani Chaulagain, Chieh-Lin Fu

Blood (2023) 142 (Supplement 1): 2408.

https://doi.org/10.1182/blood-2023-172785

Published: 2023

Journal Articles

Chemotherapy Refusal Patterns in Multiple Myeloma Patients: An in-Depth Analysis of the NCDB Data from 2004 to 2020

Ludovic Saba, Chieh-Lin Fu, Kaylee Sarna, Hong Liang, Barbara Geraldine Dominguez, Chakra Pani Chaulagain

Blood (2023) 142 (Supplement 1): 4697.

https://doi.org/10.1182/blood-2023-181158

Published: 2023

Journal Articles

Exploring Autologous Hematopoietic Stem Cell Transplantation (HSCT) Utilization and HSCT Refusal Trends in Multiple Myeloma Patients: A Comprehensive Examination of NCDB Data from 2004 to 2020

Chakra Pani Chaulagain, Ludovic Saba, Kaylee Sarna, Hong Liang, Barbara Geraldine Dominguez, Chieh-Lin Fu

Blood (2023) 142 (Supplement 1): 532.

https://doi.org/10.1182/blood-2023-182051

Published: 2023

Journal Articles

MPO and Trh within Leukemia Stem Cells Increased Chemosensitivity in Acute Myeloid Leukemia: A Single-Cell RNA Sequencing Approach

Chieh-Lin Jerry Teng, Chung-Hsing Chen, Tzu‐Hung Hsiao, Ting-Shuan Wu, Yu-Min Liao

Blood (2023) 142 (Supplement 1): 4323.

https://doi.org/10.1182/blood-2023-174175

Published: 2023

Journal Articles

Determinants of Overall Survival (OS) of Waldenstrom Macroglobulinemia (WM): A National Cancer Database (NCDB) Analysis of over 14,000 Patients Treated between Years 2004 and 2017

Chakra P Chaulagain, Kevin Landau, Hong Liang, Chieh-Lin Fu

Blood (2022) 140 (Supplement 1): 9333–9334.

https://doi.org/10.1182/blood-2022-159043

Published: 2022

Journal Articles

Predictors of Hospitalizations and Death from COVID-19 in Patients with Multiple Myeloma

Chakra P Chaulagain, Maroun Bou Zerdan, Jack Khouri, Beth M. Faiman, Faiz Anwer, Chieh-Lin Fu, Jason Valent

Blood (2022) 140 (Supplement 1): 12530–12531.

https://doi.org/10.1182/blood-2022-157865

Published: 2022

Journal Articles

Characteristics and Treatment Response of Newly Diagnosed Advanced-Stage and Relapsed/Refractory Hodgkin Lymphoma in Taiwan: A Nationwide Retrospective Study

Chieh-Lin Jerry Teng, Tran-Der Tan, MD, Yu-Wen Lin, Pei-Wen Lien, Hsin-Chun Chou, Fang-Ju Lin

Blood (2020) 136 (Supplement 1): 30.

https://doi.org/10.1182/blood-2020-141186

Published: 2020

Journal Articles

Niemann-Pick disease with isolated leukemic nonnodal mantle cell lymphoma of the spleen

Chieh Lin Fu, Maria Julia Diacovo

Blood (2020) 135 (10): 778.

https://doi.org/10.1182/blood.2019003479

Published: 2020

Journal Articles

Comparison of Molecular Responses between e14a2 and e13a2 BCR-ABL1 Transcripts in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Front-Line Second Generation Tyrosine Kinase Inhibitors: Taiwan CML Study

Yi-Jiun Su, MD, Ming-Chung Kuo, MD, Chieh-Lin Teng, MD, Tsai-Yun Chen, MD, Ming-Chun Ma, MD, Pei-Ching Hsiao, MD, Ming-Chung Wang, MD, Tung-Huei Lin, MS, Wen-Li Hwang, MD, Chih-Cheng Chen, MD, Youngsen Yang, MD, Sung-Nan Pei, MD, Yen-Min Huang, MD, Sin-Syue Li, MD, Ming-Yang Lee, MD, Hung-I Cheng, MD, Lee-Yung Shih, MD

Blood (2017) 130 (Supplement 1): 1603.

https://doi.org/10.1182/blood.V130.Suppl_1.1603.1603

Published: 2017

Journal Articles

RNA-Seq Revealed an Integration of Multiple Resistance Functions for Predicting Response to the "7+3" Induction Chemotherapy of De Novo Acute Myeloid Leukemia

Yu-Chiao Chiu, PhD, Tzu-Chieh Ho, PhD, Jia-Rong Tsai, Li-Ju Wang, MS, Shih-Lan Hsu, PhD, Yidong Chen, PhD, Chieh-Lin Teng, MD, Tzu-Hung Hsiao, PhD

Blood (2017) 130 (Supplement 1): 2485.

https://doi.org/10.1182/blood.V130.Suppl_1.2485.2485

Published: 2017

Journal Articles

CD14 Mediates Phagocytic Activity during the Granulocytic Differentiation Process in Acute Promyelocytic Leukemia Cells

Hui-Chi Hsu, MD, Wen-Hui Tsai, PhD, Yu-Chieh Lin, MA

Blood (2014) 124 (21): 4955.

https://doi.org/10.1182/blood.V124.21.4955.4955

Published: 2014

Journal Articles

Assessment of Safety and Efficacy of a New Intravenous Immunoglobulin (IGIV3I 10% Grifols) In Subjects with Chronic Immune Thrombocytopenia

Blood (2010) 116 (21): 4669.

https://doi.org/10.1182/blood.V116.21.4669.4669

Published: 2010

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Safety and efficacy of surovatamig (AZD0486) in adolescent and adult patients with relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL): Updated Results from the Phase 1/2 SYRUS study

Genetic evolution in CML patients from diagnosis to TKI failure: An analysis of 121 paired diagnosis and treatment failure samples

Acalabrutinib versus venetoclax plus obinutuzumab in treatment-naive chronic lymphocytic leukemia: A real-world propensity score-matched study

Real World Experience with Time Limited Venetoclax and Obinutuzumab (VO) for Frontline Treatment of CLL/SLL with MRD Determination By Clonoseq®

Doxorubicin Synergizes Bortezomib-Induced Multiple Myeloma Cell Death By Inhibiting Aggresome Formation Leading to ER Stress and Apoptosis

Pomalidomide Induces Myeloma Cell Death Via GPX4-Mediated Ferroptosis

Real-World Treatment Patterns and Outcomes of Solitary Plasmacytoma in the United States: A National Cancer Database (NCDB) Analysis of Years 2004-2020

Final Results of a Phase I/II Trial of Carfilzomib + R-CHOP for Frontline Treatment of Patients with Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL)

No Survival Disparity between Black and White Patient's with Stage I/II Diffuse Large B-Cell Lymphoma and It's Significance

Chemotherapy Refusal Patterns in Multiple Myeloma Patients: An in-Depth Analysis of the NCDB Data from 2004 to 2020

Exploring Autologous Hematopoietic Stem Cell Transplantation (HSCT) Utilization and HSCT Refusal Trends in Multiple Myeloma Patients: A Comprehensive Examination of NCDB Data from 2004 to 2020

MPO and Trh within Leukemia Stem Cells Increased Chemosensitivity in Acute Myeloid Leukemia: A Single-Cell RNA Sequencing Approach

Determinants of Overall Survival (OS) of Waldenstrom Macroglobulinemia (WM): A National Cancer Database (NCDB) Analysis of over 14,000 Patients Treated between Years 2004 and 2017

Predictors of Hospitalizations and Death from COVID-19 in Patients with Multiple Myeloma

Characteristics and Treatment Response of Newly Diagnosed Advanced-Stage and Relapsed/Refractory Hodgkin Lymphoma in Taiwan: A Nationwide Retrospective Study

Niemann-Pick disease with isolated leukemic nonnodal mantle cell lymphoma of the spleen

Comparison of Molecular Responses between e14a2 and e13a2 BCR-ABL1 Transcripts in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Front-Line Second Generation Tyrosine Kinase Inhibitors: Taiwan CML Study

RNA-Seq Revealed an Integration of Multiple Resistance Functions for Predicting Response to the "7+3" Induction Chemotherapy of De Novo Acute Myeloid Leukemia

CD14 Mediates Phagocytic Activity during the Granulocytic Differentiation Process in Acute Promyelocytic Leukemia Cells

Assessment of Safety and Efficacy of a New Intravenous Immunoglobulin (IGIV3I 10% Grifols) In Subjects with Chronic Immune Thrombocytopenia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only